Long Term Follow-up Study of AAVAnc80-hOTOF Gene Therapy
Long Term Follow-up Study of AAVAnc80-hOTOF Gene Therapy
Enrolling by invitation · NCT06696456 · Registry updated 2026-04-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Long Term Follow-up Study of AAVAnc80-hOTOF Gene Therapy | Deafness, Deafness, Autosomal Recessive 9, Ear Diseases, Hearing Loss, Bilateral, Hearing Loss, Sensorineural, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, auditory neuropathy, hearing disorder, hearing loss disorder, nervous system disorder, otorhinolaryngologic disease | Enrolling by invitation | Not stated | 2026-04-06 | NCT06696456 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Akouos, Inc. | 4 |
| Eli Lilly and Company | 370 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Boston Children's Hospital | Boston | United States | 343 |
| Children's Hospital of Philadelphia | Philadelphia | United States | 22 |
| Hospital Sant Joan de Déu | Esplugues de Llobregat | Spain | 9 |
| National Taiwan University Hospital | Taipei | Taiwan | 1 |
| University of Iowa | Iowa City | United States | 284 |